SOHM Inc (OTCMKTS: SHMN) skyrocketed into pennyland and is now heading northbound in a hurry as investors continue to heavily accumulate. SHMN has been running since last September but has heated in recent days transforming into a top traded stocks in small caps. Volume has been picking up significantly in recent days with SHMN trading over $6 million in dollar volume on Tuesday alone as some of the top penny stock speculators jump onto the SHNN train.
SHMN is an exciting Company in small caps that has been getting noticed by investors as the Company recently became “pink current” SHMN develops, manufactures and markets generic pharmaceuticals in various dosage forms, including tablets and capsules, creams and topicals, ointments, liquids and injectables. At present, SHMN has global licenses to manufacture more than 15 products and approximately 300 generic drugs and product formulations for distribution. In 2020 SOHM launched a new CBD product line that is now selling at Publix and Walmart according to management. the Company continues the development and introduction of its first new personal care topical product CBD Pain Relief Cream. SOHM also plans to introduce its second product in near future in the same product line. Other products include Nail Renovar-Nail Fungus treatment, Hand Sanitizer Spray with Aloe Vera, Anti-Microbial Multi-Purpose Spray, Anti-Microbial Hand Soap- Personal Care and Non-Alcoholic Hand Sanitizer Gel-Personal Care.
SOHM Inc (OTCMKTS: SHMN) is a growing generic pharmaceutical manufacturing and marketing company with a vision “Globalè Prospèro” that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as has strategic alliances with US manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia. SOHM is a recognized Pharma Company on the FDA list. SOHM online store is located here.
The Company produces Generic Drugs and its strategic manufacturing facility enables low production costs without compromising quality. SHMN develops, manufactures and markets generic pharmaceuticals in various dosage forms, including tablets and capsules, creams and topicals, ointments, liquids and injectables. At present, SHMN has global licenses to manufacture more than 15 products and approximately 300 generic drugs and product formulations for distribution. SOHM manufacturing alliance partner operates a 20,000 square ft. Southern California facility that is FDA certified and OTC and Prescription (Rx) drug and cGMP compliant. They specialize in product development and the manufacture of skin, hair, and body care products as well as color cosmetics. This manufacturing house not only has over 4500 formulas available and accessible to us but, has the capability to modify these formulas to suit our as well as our client’s needs.
To Find out the inside Scoop on SHMN Subscribe to Microcapdaily Right Now by entering your Email in the box below


In 2020 SOHM launched a new CBD product line that is now selling at Publix and Walmart according to management. the Company continues the development and introduction of its first new personal care topical product CBD Pain Relief Cream. The company also plans to introduce its second product in near future in the same product line. Other products include Nail Renovar-Nail Fungus treatment, Hand Sanitizer Spray with Aloe Vera, Anti-Microbial Multi-Purpose Spray, Anti-Microbial Hand Soap- Personal Care and Non-Alcoholic Hand Sanitizer Gel-Personal Care
SHMN products under National Drug codes include: 50405-0001 SohMed Extra Strength SOHM Inc. 500 mg/1 ACETAMINOPHEN TABLET, 50405-0002 SohMed Acid Reducer SOHM Inc. 105 mg/1 MAGNESIUM CARBONATE TABLET, CHEWABLE, 50405-0003 SohMed Allergy Sinus SOHM Inc. 5 mg/1 PHENYLEPHRINE HYDROCHLORIDE TABLET to name a few, for a more comprehensive list go here.
On April 27 SHMN reported it has signed a Letter of Intent for Acquisition of a leading Southern California based pharmaceutical company. Mr. Baron Night, President and CEO of SOHM Inc. said, “We are very pleased to announce that after establishing the strategic manufacturing and marketing of generic Pharmaceutical, Cosmeceuticals, Personal care and Nutraceutical products range within USA, for SOHM it is a logical expansion to establish its brand name in the ever-growing generic prescription pharmaceutical and OTC market in USA. With this possible acquisition, after due diligence, SOHM would have an established distribution network in the various states” Mr. Night added that the proposed target of pharmaceutical manufacturing company is in manufacturing and supply to third party and private label manufacturing for last 20 years. The company has more than 300+ formulation ranging from OTC to prescription to skincare to cosmeceuticals as well as veterinary segments. The company has license to manufacture, prescription, OTC and cosmeceutical products.
Besides this SOHM would also have the opportunity to manufacture in house its products in the US brands in its manufacturing facility at Southern California thus increasing the profitability. If this proposed acquisition goes through, it is in line with the Company’s strategy for its growth and stability and bring synergies between the two companies. Mr. Night went on to say that this will be one of the organic takeovers and is subject to appropriate Due diligence and it is going to be on cash basis, subject to procuring the financing needs by institutional loan or capital raise. Together with SOHM management bandwidth the all its segments will witness more applied innovation in time to come. The company anticipates announcing its definitive agreement after proper due diligence and procuring confirmed financing methods within 2nd qtr. 2021 or early 3rd qtr.
For More on SHMN Subscribe Right Now
SHMN skyrocketed into pennyland and is now heading northbound in a hurry as investors continue to heavily accumulate. SHMN has been running since last September but has heated in recent days transforming into a top traded stocks in small caps. Volume has been picking up significantly in recent days with SHMN trading over $6 million in dollar volume on Tuesday alone as some of the top penny stock speculators jump onto the SHNN train. SHMN is an exciting Company in small caps that has been getting noticed by investors as the Company recently became “pink current” SHMN develops, manufactures and markets generic pharmaceuticals in various dosage forms, including tablets and capsules, creams and topicals, ointments, liquids and injectables. At present, SHMN has global licenses to manufacture more than 15 products and approximately 300 generic drugs and product formulations for distribution. In 2020 SOHM launched a new CBD product line that is now selling at Publix and Walmart according to management. the Company continues the development and introduction of its first new personal care topical product CBD Pain Relief Cream. SOHM also plans to introduce its second product in near future in the same product line. Other products include Nail Renovar-Nail Fungus treatment, Hand Sanitizer Spray with Aloe Vera, Anti-Microbial Multi-Purpose Spray, Anti-Microbial Hand Soap- Personal Care and Non-Alcoholic Hand Sanitizer Gel-Personal Care. We will be updating on SHMN when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with SHMN.
Disclosure: we hold no position in SHMN either long or short and we have not been compensated for this article.